The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study

G. Banfi, M. Moriggi, E. Sabadini, G. Fellin, G. D'Amico, C. Ponticelli

Research output: Contribution to journalArticle

142 Citations (Scopus)

Abstract

In this retrospective study we report the outcome of 59 adults with idiopathic focal-segmental glomerulosclerosis (FSGS) and nephrotic syndrome (NS) treated with corticosteroids and/or immunosuppressive drugs. Twenty-seven patients were initially treated with corticosteroids alone for 9.3 ± 8 months; nineteen patients received corticosteroids and immunosuppressive agents associated or every other month for 5.5 ± 4 months; thirteen patients received either azathioprine or cyclophosphamide alone for 25 ± 27 months. At the end of a mean follow-up of 75 ± 51 months, 35 patients (60%) were in complete (CR) or partial (PR) remission, 6 (10%) were stable and 18 (30%) had either chronic renal failure (CRF) or end-stage renal failure (ESRF). Out of 36 patients (61%) initially responsive to therapy, 30 (83%) obtained CR, 4 (11%) PR, one (2.7%) developed CRF and one (2.7%) ESRF. Only 10 of the responders (28%) attained remission within 8 weeks of treatment. Out of the 23 (39%) patients originally resistant to therapy, only (4%) had CR, 6 (26%) remained unchanged, 6 (26%) developed CRF and 10 (43%) ESRF. The presence at initial renal biopsy of interstitial fibrosis was the only feature which could predict a poor renal outcome. These data show that prolonged treatment of FSGS can obtain sustained remission of the disease and improved renal survival in a consistent proportion of adult patients which would be considered refractory to a two-month course with corticosteroids.

Original languageEnglish
Pages (from-to)53-59
Number of pages7
JournalClinical Nephrology
Volume36
Issue number2
Publication statusPublished - 1991

Fingerprint

Focal Segmental Glomerulosclerosis
Nephrotic Syndrome
Immunosuppression
Chronic Kidney Failure
Retrospective Studies
Adrenal Cortex Hormones
Immunosuppressive Agents
Kidney
Azathioprine
Therapeutics
Cyclophosphamide
Fibrosis
Biopsy
Pharmaceutical Preparations

Keywords

  • corticosteroids
  • focal-segmental glomerulosclerosis
  • immunosuppressive drugs
  • nephrotic syndrome

ASJC Scopus subject areas

  • Nephrology

Cite this

The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. / Banfi, G.; Moriggi, M.; Sabadini, E.; Fellin, G.; D'Amico, G.; Ponticelli, C.

In: Clinical Nephrology, Vol. 36, No. 2, 1991, p. 53-59.

Research output: Contribution to journalArticle

@article{3e317d1061774d8f88b870cf2d230646,
title = "The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study",
abstract = "In this retrospective study we report the outcome of 59 adults with idiopathic focal-segmental glomerulosclerosis (FSGS) and nephrotic syndrome (NS) treated with corticosteroids and/or immunosuppressive drugs. Twenty-seven patients were initially treated with corticosteroids alone for 9.3 ± 8 months; nineteen patients received corticosteroids and immunosuppressive agents associated or every other month for 5.5 ± 4 months; thirteen patients received either azathioprine or cyclophosphamide alone for 25 ± 27 months. At the end of a mean follow-up of 75 ± 51 months, 35 patients (60{\%}) were in complete (CR) or partial (PR) remission, 6 (10{\%}) were stable and 18 (30{\%}) had either chronic renal failure (CRF) or end-stage renal failure (ESRF). Out of 36 patients (61{\%}) initially responsive to therapy, 30 (83{\%}) obtained CR, 4 (11{\%}) PR, one (2.7{\%}) developed CRF and one (2.7{\%}) ESRF. Only 10 of the responders (28{\%}) attained remission within 8 weeks of treatment. Out of the 23 (39{\%}) patients originally resistant to therapy, only (4{\%}) had CR, 6 (26{\%}) remained unchanged, 6 (26{\%}) developed CRF and 10 (43{\%}) ESRF. The presence at initial renal biopsy of interstitial fibrosis was the only feature which could predict a poor renal outcome. These data show that prolonged treatment of FSGS can obtain sustained remission of the disease and improved renal survival in a consistent proportion of adult patients which would be considered refractory to a two-month course with corticosteroids.",
keywords = "corticosteroids, focal-segmental glomerulosclerosis, immunosuppressive drugs, nephrotic syndrome",
author = "G. Banfi and M. Moriggi and E. Sabadini and G. Fellin and G. D'Amico and C. Ponticelli",
year = "1991",
language = "English",
volume = "36",
pages = "53--59",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "2",

}

TY - JOUR

T1 - The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study

AU - Banfi, G.

AU - Moriggi, M.

AU - Sabadini, E.

AU - Fellin, G.

AU - D'Amico, G.

AU - Ponticelli, C.

PY - 1991

Y1 - 1991

N2 - In this retrospective study we report the outcome of 59 adults with idiopathic focal-segmental glomerulosclerosis (FSGS) and nephrotic syndrome (NS) treated with corticosteroids and/or immunosuppressive drugs. Twenty-seven patients were initially treated with corticosteroids alone for 9.3 ± 8 months; nineteen patients received corticosteroids and immunosuppressive agents associated or every other month for 5.5 ± 4 months; thirteen patients received either azathioprine or cyclophosphamide alone for 25 ± 27 months. At the end of a mean follow-up of 75 ± 51 months, 35 patients (60%) were in complete (CR) or partial (PR) remission, 6 (10%) were stable and 18 (30%) had either chronic renal failure (CRF) or end-stage renal failure (ESRF). Out of 36 patients (61%) initially responsive to therapy, 30 (83%) obtained CR, 4 (11%) PR, one (2.7%) developed CRF and one (2.7%) ESRF. Only 10 of the responders (28%) attained remission within 8 weeks of treatment. Out of the 23 (39%) patients originally resistant to therapy, only (4%) had CR, 6 (26%) remained unchanged, 6 (26%) developed CRF and 10 (43%) ESRF. The presence at initial renal biopsy of interstitial fibrosis was the only feature which could predict a poor renal outcome. These data show that prolonged treatment of FSGS can obtain sustained remission of the disease and improved renal survival in a consistent proportion of adult patients which would be considered refractory to a two-month course with corticosteroids.

AB - In this retrospective study we report the outcome of 59 adults with idiopathic focal-segmental glomerulosclerosis (FSGS) and nephrotic syndrome (NS) treated with corticosteroids and/or immunosuppressive drugs. Twenty-seven patients were initially treated with corticosteroids alone for 9.3 ± 8 months; nineteen patients received corticosteroids and immunosuppressive agents associated or every other month for 5.5 ± 4 months; thirteen patients received either azathioprine or cyclophosphamide alone for 25 ± 27 months. At the end of a mean follow-up of 75 ± 51 months, 35 patients (60%) were in complete (CR) or partial (PR) remission, 6 (10%) were stable and 18 (30%) had either chronic renal failure (CRF) or end-stage renal failure (ESRF). Out of 36 patients (61%) initially responsive to therapy, 30 (83%) obtained CR, 4 (11%) PR, one (2.7%) developed CRF and one (2.7%) ESRF. Only 10 of the responders (28%) attained remission within 8 weeks of treatment. Out of the 23 (39%) patients originally resistant to therapy, only (4%) had CR, 6 (26%) remained unchanged, 6 (26%) developed CRF and 10 (43%) ESRF. The presence at initial renal biopsy of interstitial fibrosis was the only feature which could predict a poor renal outcome. These data show that prolonged treatment of FSGS can obtain sustained remission of the disease and improved renal survival in a consistent proportion of adult patients which would be considered refractory to a two-month course with corticosteroids.

KW - corticosteroids

KW - focal-segmental glomerulosclerosis

KW - immunosuppressive drugs

KW - nephrotic syndrome

UR - http://www.scopus.com/inward/record.url?scp=0025880389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025880389&partnerID=8YFLogxK

M3 - Article

C2 - 1934660

AN - SCOPUS:0025880389

VL - 36

SP - 53

EP - 59

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 2

ER -